Revenio Group Oyj (OTCMKTS:REVXF – Get Free Report) saw a large increase in short interest in the month of May. As of May 29th, there was short interest totaling 12,217 shares, an increase of 5,530.0% from the May 14th total of 217 shares. Based on an average trading volume of 430 shares, the days-to-cover ratio is presently 28.4 days.
Revenio Group Oyj Price Performance
Shares of REVXF opened at $16.41 on Thursday. The stock has a 50-day moving average of $18.34 and a two-hundred day moving average of $21.26. Revenio Group Oyj has a one year low of $16.41 and a one year high of $16.54.
Revenio Group Oyj Company Profile
Revenio Group Oyj is a Finland?based medical technology company specializing in ophthalmic diagnostic instruments. The company’s core business centers on the design, manufacture and sales of intraocular pressure (IOP) measurement devices that support glaucoma screening, diagnosis and long?term patient monitoring. Utilizing patented rebound tonometry technology, Revenio’s tonometers provide rapid, non-invasive IOP readings without the need for topical anesthesia, making them well?suited for both clinical and home settings.
Revenio’s product portfolio is anchored by the Icare® family of tonometers, which includes the Icare PRO for clinical use and the Icare HOME for patient self-monitoring.
Featured Articles
- Five stocks we like better than Revenio Group Oyj
- Everpure: AI Storage Uncertainty Overshadows Breakneck Growth
- This Tech ETF Is Beating QQQ—and Canada May Be Part of the Reason
- Intel Is the Market’s Most Mispriced AI Hedge
- The Biggest Opportunity From SpaceX’s IPO May Surprise You
Receive News & Ratings for Revenio Group Oyj Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Revenio Group Oyj and related companies with MarketBeat.com's FREE daily email newsletter.
